Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Origuchi

Showing results (61-70 of 227) with videos related to

Pageof 23
Sort By:
The Journal of Laboratory and Clinical Medicine|September 1, 2005
A cross-talk between RNA splicing and signaling pathway alters Fas gene expression at post-transcriptional level: alternative splicing of Fas mRNA in the leukemic U937 cellsKouichiro Aratake, Makoto Kamachi, Nozomi Iwanaga, et al.
Modern Rheumatology|March 14, 2009
A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritisToshiyuki Aramaki, Hiroaki Ida, Yasumori Izumi, et al.
Cytotechnology|September 29, 2009
Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysisHiroaki Ida, Toshiyuki Aramaki, Hideki Nakamura, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexateFumiko Tanaka, Atsushi Kawakami, Nozomi Iwanaga, et al.
Internal Medicine (Tokyo, Japan)|December 21, 2018
A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV MutationsSeiko Nakamichi, Tomoki Origuchi, Shoichi Fukui, et al.
International Journal of Molecular Medicine|April 5, 2005
IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expressionFumiko Tanaka, Atsushi Kawakami, Mami Tamai, et al.
Modern Rheumatology|July 14, 2020
Contributing factors of clinical outcomes at 1 year post-diagnosis in early rheumatoid arthritis patients with tightly controlled disease activity in clinical practice: a retrospective studyShin-Ya Kawashiri, Yushiro Endo, Momoko Okamoto, et al.
International Journal of Rheumatic Diseases|January 30, 2024
The double shared epitope: Its impact on clinical features and ultrasound findings in rheumatoid arthritisTohru Michitsuji, Shoichi Fukui, Ayako Nishino, et al.
Journal of Immunology Research|September 7, 2018
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010Kunihiro Ichinose, Toshimasa Shimizu, Masataka Umeda, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2018
Evaluation of circulating invariant T cells before and after IL-17 inhibitor treatment in a patient with psoriatic arthritisTomohiro Koga, Megumi Matoba, Tomohito Sato, et al.
Pageof 23

Showing results (61-70 of 227) with videos related to

Sort By:
Pageof 23
The Journal of Laboratory and Clinical Medicine|September 1, 2005
A cross-talk between RNA splicing and signaling pathway alters Fas gene expression at post-transcriptional level: alternative splicing of Fas mRNA in the leukemic U937 cellsKouichiro Aratake, Makoto Kamachi, Nozomi Iwanaga, et al.
Modern Rheumatology|March 14, 2009
A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritisToshiyuki Aramaki, Hiroaki Ida, Yasumori Izumi, et al.
Cytotechnology|September 29, 2009
Different expression levels of TNF receptors on the rheumatoid synovial macrophages derived from surgery and a synovectomy as detected by a new flow cytometric analysisHiroaki Ida, Toshiyuki Aramaki, Hideki Nakamura, et al.
Internal Medicine (Tokyo, Japan)|April 6, 2006
Infliximab is effective for Takayasu arteritis refractory to glucocorticoid and methotrexateFumiko Tanaka, Atsushi Kawakami, Nozomi Iwanaga, et al.
Internal Medicine (Tokyo, Japan)|December 21, 2018
A Rare Case of Cryopyrin-associated Periodic Syndrome in an Elderly Woman with NLRP3 and MEFV MutationsSeiko Nakamichi, Tomoki Origuchi, Shoichi Fukui, et al.
International Journal of Molecular Medicine|April 5, 2005
IFN-gamma/JAK/STAT pathway-induced inhibition of DR4 and DR5 expression on endothelial cells is cancelled by cycloheximide-sensitive mechanism: novel finding of cycloheximide-regulating death receptor expressionFumiko Tanaka, Atsushi Kawakami, Mami Tamai, et al.
Modern Rheumatology|July 14, 2020
Contributing factors of clinical outcomes at 1 year post-diagnosis in early rheumatoid arthritis patients with tightly controlled disease activity in clinical practice: a retrospective studyShin-Ya Kawashiri, Yushiro Endo, Momoko Okamoto, et al.
International Journal of Rheumatic Diseases|January 30, 2024
The double shared epitope: Its impact on clinical features and ultrasound findings in rheumatoid arthritisTohru Michitsuji, Shoichi Fukui, Ayako Nishino, et al.
Journal of Immunology Research|September 7, 2018
Frequency of Hospitalized Infections Is Reduced in Rheumatoid Arthritis Patients Who Received Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs after 2010Kunihiro Ichinose, Toshimasa Shimizu, Masataka Umeda, et al.
Clinical Immunology (Orlando, Fla.)|September 25, 2018
Evaluation of circulating invariant T cells before and after IL-17 inhibitor treatment in a patient with psoriatic arthritisTomohiro Koga, Megumi Matoba, Tomohito Sato, et al.
Pageof 23